123 related articles for article (PubMed ID: 37753543)
21. Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.
Tas F; Erturk K
Jpn J Clin Oncol; 2021 May; 51(6):873-878. PubMed ID: 33758939
[TBL] [Abstract][Full Text] [Related]
22. Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma.
Tas F; Erturk K
Mol Clin Oncol; 2017 Dec; 7(6):1142-1146. PubMed ID: 29285390
[TBL] [Abstract][Full Text] [Related]
23. Interaction between Age and Primary Site on Survival Outcomes in Primary GI Melanoma over the Past Decade.
Bangolo A; Fwelo P; Sagireddy S; Shah H; Trivedi C; Bukasa-Kakamba J; Patel R; Bharane L; Randhawa MK; Nagesh VK; Dey S; Terefe H; Kaur G; Dinko N; Emiroglu FL; Mohamed A; Fallorina MA; Kosoy D; Waqar D; Shenoy A; Ahmed K; Nanavati A; Singh A; Willie A; Gonzalez DMC; Mukherjee D; Sajja J; Proverbs-Singh T; Elias S; Weissman S
Med Sci (Basel); 2023 Apr; 11(2):. PubMed ID: 37218984
[TBL] [Abstract][Full Text] [Related]
24. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
25. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Factors and Clinical Outcomes of Clinical Node-Negative Cutaneous Malignant Melanoma Patients: An Asian Single Institute Study.
Chen YF; Ma H; Perng CK; Feng CJ
Ann Plast Surg; 2020 Jan; 84(1S Suppl 1):S48-S53. PubMed ID: 31833887
[TBL] [Abstract][Full Text] [Related]
27. Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease.
Kretschmer L; Hilgers R; Möhrle M; Balda BR; Breuninger H; Konz B; Kunte C; Marsch WC; Neumann C; Starz H
Eur J Cancer; 2004 Jan; 40(2):212-8. PubMed ID: 14728935
[TBL] [Abstract][Full Text] [Related]
28. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update.
Ishihara K; Saida T; Otsuka F; Yamazaki N;
Int J Clin Oncol; 2008 Feb; 13(1):33-41. PubMed ID: 18307017
[TBL] [Abstract][Full Text] [Related]
29. Monitoring Metastasis and Cachexia in a Patient with Breast Cancer: A Case Study.
Consul N; Guo X; Coker C; Lopez-Pintado S; Hibshoosh H; Zhao B; Kalinsky K; Acharyya S
Clin Med Insights Oncol; 2016; 10():83-94. PubMed ID: 27660506
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic Features of Cutaneous Malignant Melanoma and Their Impact on Prognosis.
Atique U; Mushtaq S; Rana IA; Hassan U
Cureus; 2020 Sep; 12(9):e10450. PubMed ID: 33072458
[TBL] [Abstract][Full Text] [Related]
31. Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
Waninger JJ; Ma VT; Journey S; Skvarce J; Chopra Z; Tezel A; Bryant AK; Mayo C; Sun Y; Sankar K; Ramnath N; Lao C; Sussman JB; Fecher L; Alva A; Green MD
JAMA Netw Open; 2021 Mar; 4(3):e210980. PubMed ID: 33687443
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Melanoma Res; 2003 Feb; 13(1):35-43. PubMed ID: 12569283
[TBL] [Abstract][Full Text] [Related]
33. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
34. Degree of desmoplasia in metastatic lymph node lesions is associated with lesion size and poor prognosis in pancreatic cancer patients.
Nakayama H; Ohuchida K; Yoshida M; Miyazaki T; Takesue S; Abe T; Endo S; Koikawa K; Okumura T; Moriyama T; Nakata K; Miyasaka Y; Shirahane K; Manabe T; Ohtsuka T; Toma H; Tominaga Y; Nagai E; Mizumoto K; Oda Y; Nakamura M
Oncol Lett; 2017 Sep; 14(3):3141-3147. PubMed ID: 28927058
[TBL] [Abstract][Full Text] [Related]
35. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
Tas F; Kurul S; Camlica H; Topuz E
Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
[TBL] [Abstract][Full Text] [Related]
36. An evidence-based staging system for cutaneous melanoma.
Balch CM; Soong SJ; Atkins MB; Buzaid AC; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
CA Cancer J Clin; 2004; 54(3):131-49; quiz 182-4. PubMed ID: 15195788
[TBL] [Abstract][Full Text] [Related]
37. Invasive Cutaneous Melanoma: Evaluating the Prognostic Significance of Some Parameters Associated with Lymph Node Metastases.
Vița O; Jurescu A; Văduva A; Cornea R; Cornianu M; Tăban S; Szilagyi D; Micșescu C; Natarâș B; Dema A
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512052
[No Abstract] [Full Text] [Related]
38. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Partl R; Richtig E; Avian A; Berghold A; Kapp KS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
[TBL] [Abstract][Full Text] [Related]
39. Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy.
Weide B; Richter S; Büttner P; Leiter U; Forschner A; Bauer J; Held L; Eigentler TK; Meier F; Garbe C
PLoS One; 2013; 8(11):e81624. PubMed ID: 24312329
[TBL] [Abstract][Full Text] [Related]
40. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma.
van Akkooi AC; Bouwhuis MG; van Geel AN; Hoedemaker R; Verhoef C; Grunhagen DJ; Schmitz PI; Eggermont AM; de Wilt JH
Eur J Surg Oncol; 2007 Feb; 33(1):102-8. PubMed ID: 17161577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]